The impact of substance abuse on the course of bipolar disorder.
- Authors
- Strakowski, S M; DelBello, M P; Fleck, D E; Arndt, S
- Year
- 2000
- Journal
- Biological psychiatry
- PMID
- 11018221
- DOI
- 10.1016/s0006-3223(00)00900-8
BACKGROUND: Substance abuse occurs at high rates in bipolar disorder. The reasons for this co-occurrence are unknown. Alcohol use disorders have been associated with both earlier and later age of onset of bipolar disorder, in part based on the temporal associations of the two conditions. Both drug and alcohol use disorders are associated with impaired outcome of bipolar illness. This influence may involve both direct effects of alcohol or drugs on the initiation of affective symptoms and indirect effects on treatment compliance. To extend these previous findings we examined the temporal associations of substance abuse and affective symptoms in patients with new onset bipolar disorder. METHODS: Associations between affective symptoms and alcohol and cannabis use disorder symptoms were evaluated using regression and time-series correlative methods in 50 new-onset bipolar patients. RESULTS: The duration of alcohol abuse during follow-up was associated with the time patients experienced depression. The duration of cannabis abuse was associated with the duration of mania. Several subgroups could be identified with different temporal relationships among these disorders. CONCLUSIONS: Although the relationships among substance use and bipolar disorders are complex, systematic study of the courses of the disorders might clarify how these conditions interact longitudinally. As the numbers of subjects in specific subgroups are relatively small in this study, these results should be considered preliminary.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The highs and lows: Cannabis use and positive valence bipolar mood and emotion processes in emerging adults. | Rosa L et al. | β | 2026 | β |
| Bipolar II disorder: a state-of-the-art review. | Berk M et al. | β | 2025 | β |
| Cannabis and tobacco use in bipolar disorder: Associations with early onset, psychotic symptoms, and relapse risk (2015-2019). | Olivier L et al. | β | 2025 | β |
| Comprehensive Review on Association of Bipolar Disorder and Substance Abuse: Dual Diagnosis and Treatment Approaches. | Bonner-Reid FT et al. | β | 2025 | β |
| Co-Occurring Bipolar and Substance Use Disorders: A Review of Impacts, Biopsychosocial Mechanisms, Assessment, and Treatment. | Sperry SH et al. | β | 2025 | β |
| Decoding the bidirectional links between alcohol misuse and aggression: toward a unified translational framework. | Russell NM et al. | β | 2025 | β |
| Frequency and Intensity of Depressive Symptoms and Frequency of Prescribed Opioid Use Among Older Adults in the United States: Results of a National Survey. | Zhu X et al. | β | 2025 | β |
| Nucleus accumbens functional connectivity changes underlying alcohol expectancies in bipolar disorder and prospective alcohol outcomes: a within-subject randomized placebo-controlled alcohol administration fMRI study. | Lippard ETC et al. | β | 2025 | β |
| Longitudinal Interplay Between Alcohol Use, Mood, and Functioning in Bipolar Spectrum Disorders. | Sperry SH et al. | β | 2024 | β |
| Psychosocial and Psychopharmacological Interventions for Comorbid Bipolar Disorder and Substance Use Disorders: A Review. | O'Hearn B et al. | β | 2024 | β |
| Alcohol Cue Processing in Co-Occurring Bipolar Disorder and Alcohol Use Disorder. | Mellick WH et al. | β | 2023 | β |
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | Preuss UW et al. | β | 2023 | β |
| Assessments of functional outcomes and its determinants among bipolar disorder patients in Northwest Ethiopia comprehensive specialized hospitals: a multicenter hospital-based study. | Mengistu ME et al. | β | 2023 | β |
| Cannabis update: Anxiety disorders and post-traumatic stress disorder. | Haycraft AL | β | 2023 | β |
| Cannabis use and its relationship with bipolar disorder: A systematic review and meta-analysis. | Maggu G et al. | β | 2023 | β |
| Incidence of and risk factors for alcohol dependence in bipolar disorder: A population-based cohort and nested case-control study. | Hsu HE et al. | β | 2023 | β |
| Molecular mechanisms of alcohol's effects on the human body: A review and update. | Renu K et al. | β | 2023 | β |
| Role of TNF-Ξ± -308G/A Polymorphism in Bipolar Disorder and its Relationship with Clinical and Demographic Variables. | Akram S et al. | β | 2023 | β |
| Subjective response to alcohol in young adults with bipolar disorder and recent alcohol use: a within-subject randomized placebo-controlled alcohol administration study. | Lippard ETC et al. | β | 2023 | β |
| Alcohol Use and Prefrontal Cortex Volume Trajectories in Young Adults with Mood Disorders and Associated Clinical Outcomes. | Kirsch DE et al. | β | 2022 | β |
| Cannabis use and medication nonadherence in bipolar disorder: A nationwide inpatient sample database analysis. | Oladunjoye AF et al. | β | 2022 | β |
| Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder. | Attar R et al. | β | 2022 | β |
| Prevalence and association of comorbid substance dependence on the course and outcome of bipolar disorder: Findings from the bipolar disorder course and outcome study from India (BiD-CoIN study). | Grover S et al. | β | 2022 | β |
| Effects of psychotherapy on comorbid bipolar disorder and substance use disorder: A systematic review. | Crowe M et al. | β | 2021 | β |
| Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review. | Stanciu CN et al. | β | 2021 | β |
| Recent Perceived Stress, Amygdala Reactivity to Acute Psychosocial Stress, and Alcohol and Cannabis Use in Adolescents and Young Adults With Bipolar Disorder. | Le V et al. | β | 2021 | β |
| Subjective response to alcohol: Associated alcohol use and orbitofrontal gray matter volume in bipolar disorder. | Tretyak V et al. | β | 2021 | β |
| A Prospective Comparison of Bipolar I and II Subjects With and Without Comorbid Alcohol Dependence From the COGA Dataset. | Preuss UW et al. | β | 2020 | β |
| Patterns and clinical correlates of lifetime alcohol consumption in women and men with bipolar disorder: Findings from the UK Bipolar Disorder Research Network. | Gordon-Smith K et al. | β | 2020 | β |
| Likelihood of depressive symptoms in US older adults by prescribed opioid potency: National Health and Nutrition Examination Survey 2005-2013. | Brooks JM et al. | β | 2019 | β |
| Predictive modeling for response to lithium and quetiapine in bipolar disorder. | Kim TT et al. | β | 2019 | β |
| Demographic, physical and mental health assessments in the adolescent brain and cognitive development study: Rationale and description. | Barch DM et al. | β | 2018 | β |
| Using Lithium in Children and Adolescents with Bipolar Disorder: Efficacy, Tolerability, and Practical Considerations. | Grant B et al. | β | 2018 | β |
| Alcohol use and bipolar disorders: Risk factors associated with their co-occurrence and sequence of onsets. | Azorin JM et al. | β | 2017 | β |
| Bipolar disorder and addictions: the elephant in the room. | Stokes PRA et al. | β | 2017 | β |
| Bipolar disorder in Asia: Illness course and contributing factors. | Subramanian K et al. | β | 2017 | β |
| Is "early intervention" in bipolar disorder what it claims to be? | Malhi GS et al. | β | 2017 | β |
| Lifetime presence of psychotic symptoms in bipolar disorder is associated with less favorable socio-demographic and certain clinical features. | Dell'Osso B et al. | β | 2017 | β |
| An open-label pilot study of icariin for co-morbid bipolar and alcohol use disorder. | Xiao H et al. | β | 2016 | β |
| Cannabis use in first-treatment bipolar I disorder: relations to clinical characteristics. | Kvitland LR et al. | β | 2016 | β |
| Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder. | Weinstock LM et al. | β | 2016 | β |
| Duration of untreated illness in first-treatment bipolar I disorder in relation to clinical outcome and cannabis use. | Kvitland LR et al. | β | 2016 | β |
| Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. | Goodwin GM et al. | β | 2016 | β |
| Affective temperaments and concomitant alcohol use disorders in bipolar disorder. | Singh S et al. | β | 2015 | β |
| Cannabis and bipolar disorder: does quitting cannabis use during manic/mixed episode improve clinical/functional outcomes? | Zorrilla I et al. | β | 2015 | β |
| Cannabis use and mania symptoms: a systematic review and meta-analysis. | Gibbs M et al. | β | 2015 | β |
| Continued cannabis use at one year follow up is associated with elevated mood and lower global functioning in bipolar I disorder. | Kvitland LR et al. | β | 2015 | β |
| Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder. | Kim SW et al. | β | 2015 | β |
| Impulsivity in bipolar and substance use disorders. | Ozten M et al. | β | 2015 | β |
| Phenomenological subtypes of mania and their relationships with substance use disorders. | GΓΌclΓΌ O et al. | β | 2015 | β |
| Relationship of clinical course of illness variables to medical comorbidities in 900 adult outpatients with bipolar disorder. | Post RM et al. | β | 2015 | β |
| The relationship between bipolar disorder and cannabis use in daily life: an experience sampling study. | Tyler E et al. | β | 2015 | β |
| Attempted suicide in people with co-occurring bipolar and substance use disorders: systematic review and meta-analysis. | CarrΓ G et al. | β | 2014 | β |
| Co-occurring psychiatric disorders and alcoholism. | Stephen Rich J et al. | β | 2014 | β |
| Illness progression as a function of independent and accumulating poor prognosis factors in outpatients with bipolar disorder in the United States. | Post RM et al. | β | 2014 | β |
| More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment. | Post RM et al. | β | 2014 | β |
| Parental history of substance use disorders (SUD) and SUD in offspring: a controlled family study of bipolar disorder. | Wilens TE et al. | β | 2014 | β |
| Substance use disorders in hospitalized psychiatric patients: the experience of one psychiatric emergency service in Turin. | Frieri T et al. | β | 2014 | β |
| The Impact of Mental Illness Stigma on Seeking and Participating in Mental Health Care. | Corrigan PW et al. | β | 2014 | β |
| Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates. | Lev-Ran S et al. | β | 2013 | β |
| Do alcohol use disorders destabilize the course of bipolar disorder? | Rakofsky JJ et al. | β | 2013 | β |
| Iowa Gambling Task scores predict future drug use in bipolar disorder outpatients with stimulant dependence. | Nejtek VA et al. | β | 2013 | β |
| Screening for bipolar disorder among outpatients with substance use disorders. | Nallet A et al. | β | 2013 | β |
| Searching the internet for health information about bipolar disorder: some cautionary issues. | Monteith S et al. | β | 2013 | β |
| The presentation, recognition and management of bipolar depression in primary care. | Cerimele JM et al. | β | 2013 | β |
| The prevalence and correlates of alcohol use disorder amongst bipolar patients in a hospital setting, Malaysia. | Yee HA et al. | β | 2013 | β |
| Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. | Tambaro S et al. | β | 2012 | β |
| Cigarette smoking and its relationship to mood disorder symptoms and co-occurring alcohol and cannabis use disorders following first hospitalization for bipolar disorder. | Heffner JL et al. | β | 2012 | β |
| Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry. | Maremmani I et al. | β | 2012 | β |
| Commentary on the study: impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate (Prisciandaro et al.). | Preuss UW | β | 2012 | β |
| Family treatment for bipolar disorder and substance abuse in late adolescence. | Miklowitz DJ | β | 2012 | β |
| Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate. | Prisciandaro JJ et al. | β | 2012 | β |
| Recovery of cognitive functioning in patients with co-occurring bipolar disorder and alcohol dependence during early remission from an acute mood episode. | Levy B et al. | β | 2012 | β |
| Stigma experiences in bipolar patients: the impact upon functioning. | ThomΓ© ES et al. | β | 2012 | β |
| The clinical management of bipolar disorder complexity using a stratified model. | Malhi GS et al. | β | 2012 | β |
| Brain functional domains inform therapeutic interventions in attention-deficit/hyperactivity disorder and pediatric bipolar disorder. | Passarotti AM et al. | β | 2011 | β |
| Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent-onset bipolar disorder. | Jerrell JM et al. | β | 2011 | β |
| Dual diagnosis and chronology of illness in treatment-seeking Italian patients dependent on heroin. | Maremmani AG et al. | β | 2011 | β |
| Effects of cannabis use on age at onset in schizophrenia and bipolar disorder. | De Hert M et al. | β | 2011 | β |
| Excessive cannabis use is associated with earlier age at onset in bipolar disorder. | Lagerberg TV et al. | β | 2011 | β |
| Integrated motivational interviewing and cognitive-behavioural therapy for bipolar disorder with comorbid substance use. | Jones SH et al. | β | 2011 | β |
| Presence of co-morbid substance use disorder in bipolar patients worsens their social functioning to the level observed in patients with schizophrenia. | Jaworski F et al. | β | 2011 | β |
| Progression of amygdala volumetric abnormalities in adolescents after their first manic episode. | Bitter SM et al. | β | 2011 | β |
| An approach to the patient with dysregulated mood: major depression and bipolar disorder. | Querques J et al. | β | 2010 | β |
| [Cannabis and mood]. | Sanches RF et al. | β | 2010 | β |
| Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included? | Pani PP et al. | β | 2010 | β |
| Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study. | GonzΓ‘lez-Pinto A et al. | β | 2010 | β |
| Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study. | Lagerberg TV et al. | β | 2010 | β |
| Impact of substance use on the physical health of patients with bipolar disorder. | Garcia-Portilla MP et al. | β | 2010 | β |
| Impulsivity across the course of bipolar disorder. | Strakowski SM et al. | β | 2010 | β |
| The ALDH2 and DRD2/ANKK1 genes interacted in bipolar II but not bipolar I disorder. | Lee SY et al. | β | 2010 | β |
| Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis. | Bortolato M et al. | β | 2010 | β |
| Behavioral approach system (BAS)-relevant cognitive styles and bipolar spectrum disorders: concurrent and prospective associations. | Alloy LB et al. | β | 2009 | β |
| Bipolar disorder preceded by substance abuse: a different phenotype with not so poor outcome? | Pacchiarotti I et al. | β | 2009 | β |
| Birth-cohort and dual diagnosis effects on age-at-onset in Brazilian patients with bipolar I disorder. | da Silva MagalhΓ£es PV et al. | β | 2009 | β |
| Characterizing impulsivity in mania. | Strakowski SM et al. | β | 2009 | β |
| Clinical predictors of functional outcome of bipolar patients in remission. | Rosa AR et al. | β | 2009 | β |
| Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients. | Baethge C et al. | β | 2009 | β |
| Cognitive functioning in bipolar and co-occurring substance use disorders: a missing piece of the puzzle. | Levy B et al. | β | 2009 | β |
| Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders. | Jaffee WB et al. | β | 2009 | β |
| Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis. | van Rossum I et al. | β | 2009 | β |
| Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. | Goodwin GM et al. | β | 2009 | β |
| Longitudinal Predictors of Bipolar Spectrum Disorders: A Behavioral Approach System (BAS) Perspective. | Alloy LB et al. | β | 2009 | β |
| Self-focused Cognitive Styles and Bipolar Spectrum Disorders: Concurrent and Prospective Associations. | Alloy LB et al. | β | 2009 | β |
| Substance use in severe mental illness: self-medication and vulnerability factors. | Bizzarri JV et al. | β | 2009 | β |
| Cannabis and psychiatric disorders: it is not only addiction. | Leweke FM et al. | β | 2008 | β |
| Cigarette smoking in the early course of bipolar disorder: association with ages-at-onset of alcohol and marijuana use. | Heffner JL et al. | β | 2008 | β |
| Cognitive performance and quality of life in bipolar disorder. | Brissos S et al. | β | 2008 | β |
| Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder. | Ringen PA et al. | β | 2008 | β |
| Does lower response to alcohol explain the high co-morbidity between bipolar disorder and alcohol dependence? | Le Strat Y et al. | β | 2008 | β |
| Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence. | UroseviΔ S et al. | β | 2008 | β |
| Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders. | Jarvis K et al. | β | 2008 | β |
| Neurocognitive impairment in patients with co-occurring bipolar disorder and alcohol dependence upon discharge from inpatient care. | Levy B et al. | β | 2008 | β |
| Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. | Baethge C et al. | β | 2008 | β |
| The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness. | Ringen PA et al. | β | 2008 | β |
| Association between illicit drug and alcohol use and first manic episode. | Frank E et al. | β | 2007 | β |
| Association of bipolar and substance use disorders in parents of adolescents with bipolar disorder. | Wilens TE et al. | β | 2007 | β |
| Cannabis use increases risk of developing symptoms of mania. | Skosnik PD | β | 2007 | β |
| Functional impairment in patients with mania: baseline results of the EMBLEM study. | Goetz I et al. | β | 2007 | β |
| Outcome following a first manic episode: cross-national US and Taiwan comparison. | Strakowski SM et al. | β | 2007 | β |
| Social functioning of bipolar offspring. | Reichart CG et al. | β | 2007 | β |
| The prevalence and significance of substance use disorders in bipolar type I and II disorder. | Cerullo MA et al. | β | 2007 | β |
| Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. | DelBello MP et al. | β | 2007 | β |
| A cognitive vulnerability-stress perspective on bipolar spectrum disorders in a normative adolescent brain, cognitive, and emotional development context. | Alloy LB et al. | β | 2006 | β |
| Cannabis use and mood disorders: patterns of clinical presentations among adolescents in a developing country. | Konings M et al. | β | 2006 | β |
| Concurrent tracking of alcohol use and bipolar disorder symptoms. | Fleck DE et al. | β | 2006 | β |
| Effects of lamotrigine in patients with bipolar disorder and alcohol dependence. | Rubio G et al. | β | 2006 | β |
| Factors associated with psychiatric hospitalization of individuals diagnosed with dementia and comorbid bipolar disorder. | Brooks JO et al. | β | 2006 | β |
| Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls. | Brooks JO et al. | β | 2006 | β |
| The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. | Post RM et al. | β | 2006 | β |
| The role of quetiapine in the treatment of bipolar disorder. | Pini S et al. | β | 2006 | β |
| Bipolar disorder and substance abuse. | Brown ES | β | 2005 | β |
| Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. | Ashton CH et al. | β | 2005 | β |
| Clinical, psychosocial, and treatment differences in minority patients with bipolar disorder. | Kilbourne AM et al. | β | 2005 | β |
| Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. | Bauer MS et al. | β | 2005 | β |
| Psychological therapies for bipolar disorder: the role of model-driven approaches to therapy integration. | Jones SH et al. | β | 2005 | β |
| Substance abuse in first-episode bipolar I disorder: indications for early intervention. | Baethge C et al. | β | 2005 | β |
| The AUDIT-C: screening for alcohol use disorders and risk drinking in the presence of other psychiatric disorders. | Dawson DA et al. | β | 2005 | β |
| A preliminary FMRI study of sustained attention in euthymic, unmedicated bipolar disorder. | Strakowski SM et al. | β | 2004 | β |
| Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. | Zanarini MC et al. | β | 2004 | β |
| Burden of general medical conditions among individuals with bipolar disorder. | Kilbourne AM et al. | β | 2004 | β |
| Cannabis and psychopathology : update 2004. | Grover S et al. | β | 2004 | β |
| Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. | Nolen WA et al. | β | 2004 | β |
| Diagnostic and symptomatological features in chronic psychotic patients according to cannabis use status. | Maremmani I et al. | β | 2004 | β |
| First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. | Green AI et al. | β | 2004 | β |
| Multiple dimensions of familial psychopathology affect risk of mood disorder in children of bipolar parents. | Wals M et al. | β | 2004 | β |
| Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. | Goodwin GM et al. | β | 2003 | β |
| Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. | Frye MA et al. | β | 2003 | β |
| Psychiatric morbidity of cannabis abuse. | Sarkar J et al. | β | 2003 | β |
| Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder. | MacQueen GM et al. | β | 2003 | β |
| Suicidal behaviour in bipolar disorder: risk and prevention. | Tondo L et al. | β | 2003 | β |
| Atypical antipsychotics in the therapy of bipolar disorders: efficacy and safety. | Di Lorenzo R et al. | β | 2002 | β |
| Quetiapine in bipolar disorder and cocaine dependence. | Brown ES et al. | β | 2002 | β |
| The Maudsley bipolar disorder project. A survey of psychotropic prescribing patterns in bipolar I disorder. | Frangou S et al. | β | 2002 | β |
| Bipolar disorder with comorbid substance abuse: diagnosis, prognosis, and treatment. | Goldberg JF | β | 2001 | β |
| Strategies to reduce misdiagnosis of bipolar depression. | Bowden CL | β | 2001 | β |
| Substance abuse in bipolar disorder. | Cassidy F et al. | β | 2001 | β |
| Bipolar disorder: can studies of natural history help us define clinically and neurobiologically relevant subtypes? | Charney DS | β | 2000 | β |